| Product Name | MF | CAS | Details |
|---|
| Boc-Gly-Sar-OH | C10H18N2O5 | 133498-97-2 | Details |
| (2S,4R)-Fmoc-L-Pro(4-N3)-OH | C20H18N4O4 | 702679-55-8 | Details |
| Acid-PEG3-SS-PEG3-acid | C18H34O10S2 | 2055014-98-5 | Details |
| Tryptamine hydrochloride | C10H13ClN2 | 343-94-2 | Details |
| 2-APQC | C23H24FN5O | 500271-63-6 | Details |
| Fmoc-L-MeLys(N3)-OH | C22H24N4O4 | 1263721-14-7 | Details |
| Hynic-PEG3-N3 | Details |
| AN317 | C13H19N3 | 946074-35-7 | Details |
| RA VII | C41H50N6O10 | 86229-97-2 | Details |
| PolQi1 | C18H14ClF5N4O2 | 2607139-80-8 | Details |
| Dioxoisoindolin-O-PEG-OMe (MW 2000) | Details |
| m-PEG-Lys-NHS ester (MW 20000) | Details |
| N3-L-Cit-OH DCHA | 2737202-65-0 | Details |
| MS7 | C24H27N5O2S2 | 1593654-46-6 | Details |
| PPO-IN-15 | C17H18ClFN4O5S | 3029518-71-3 | Details |
| EG-2184 | C15H19F6NO3S | 2770297-66-8 | Details |
| GTSE1-IN-1 | C21H24FN7 | 3002034-34-3 | Details |
| PROTAC SMARCA2/4-degrader-29 | C44H51N11O4 | 2568273-82-3 | Details |
| BMI-135 | C23H13FO2S | 1608099-90-6 | Details |
| PCSK9 allosteric binder-1 | C28H30FN3O6S | 2215932-06-0 | Details |
| 8-Hydroxy-7-methoxycoumarin | C10H8O4 | 19492-03-6 | Details |
| c-Ceritinib TFA salt | Details |
| Ethephon | C2H6ClO3P | 16672-87-0 | Details |
| C.I. 21010 | C21H25ClN8 | 5421-66-9 | Details |
| GSK2636771 methyl | C23H24F3N3O3 | 1372540-24-3 | Details |
| 4-(Azidomethyl)benzoic acid | C8H7N3O2 | 79584-03-5 | Details |
| Mal-PEG2-PFP ester | C17H14F5NO6 | 1807512-47-5 | Details |
| Propargyl-PEG1-SS-alcohol | C7H12O2S2 | 1391914-41-2 | Details |
| Propargyl-PEG4-tetra-Ac-beta-D-glucose | C25H38O14 | 1360446-31-6 | Details |
| L-ANAP | C15H16N2O3 | 1313516-26-5 | Details |
| m-PEG3-Sulfone-PEG3-acid | C16H32O10S | 1919045-04-7 | Details |
| N-(m-PEG4)-N'-(Biotin-PEG2-amido-PEG4)-Cy5 | C61H93ClN6O13S | 2107273-78-7 | Details |
| N-(m-PEG4)-N'-(PEG2-NHS ester)-Cy5 | C45H60ClN3O10 | 2107273-28-7 | Details |
| N-methyl-N'-(propargyl-PEG4)-Cy5 | C37H47ClN2O4 | 2107273-04-9 | Details |
| Methyltetrazine-DBCO | C34H33N7O7S | 1802238-48-7 | Details |
| N-(Azido-PEG2)-N-Fluorescein-PEG3-acid | C36H41N5O12S | 2086689-04-3 | Details |
| PRL3-CNNM4 interaction-IN-1 | C8H8O2S | 40133-06-0 | Details |
| NO2-SPP-sulfo-Me | C15H17N3O8S3 | 890409-87-7 | Details |
| Panaxcerol B | C27H46O9 | 171520-42-6 | Details |
| Kazusamycin A | C33H48O7 | 92090-94-3 | Details |
| REM127 | C20H20Cl2N4S | 1417823-67-6 | Details |
| NH2-C5-PEG4-N3-L-Lysine-PEG3-N3 | Details |
| Biotin-MeTz | C20H25N7O2S | 1802883-51-7 | Details |
| MC-D-Val-Cit-PAB-PNP | C35H43N7O11 | 1350456-64-2 | Details |
| DBCO-S-S-acid | C24H24N2O4S2 | 2749426-25-1 | Details |
| Poly(4-vinylphenol) | C8H8O | 24979-70-2 | Details |
| Phaseollidin | C20H20O4 | 37831-70-2 | Details |
| MT0703 | C26H25N7O9S3 | 108353-14-6 | Details |
| DHX9-IN-10 | C19H18N2O3S2 | 2973746-79-9 | Details |
| GPR183-IN-2 | C19H23BrN2O3 | 2924064-10-6 | Details |
| VU0448088 | C16H15ClN4OS | 1417616-42-2 | Details |
| Z19153 | C15H21NO2 | 2600702-14-3 | Details |
| Z21115 | C20H20F2N2O4 | 2958668-54-5 | Details |
| GLP-1R agonist 23 | C34H27F3N4O4 | 2855245-46-2 | Details |
| Antitumor agent-184 | C22H16N4O2S | 3040164-45-9 | Details |
| Ethyl undecanoate | C13H26O2 | 627-90-7 | Details |
| (±)-ANAP hydrochloride (1185251-08-4 free base) | Details |
| Isonicoteine | C10H8N2 | 581-50-0 | Details |
| A2315A | C26H37N3O7 | 58717-24-1 | Details |
| 8-Pcpt-cGMP | C16H15ClN5O7PS | 54364-02-2 | Details |
| Ald-Ph-amido-PEG2-C2-acid | C15H19NO6 | 1807534-84-4 | Details |
| HS-PEG3-CH2CH2N3 | C8H17N3O3S | 1347750-79-1 | Details |
| SN50 | C129H230N36O29S | 213546-53-3 | Details |
| Photo-lysine | C6H12N4O2 | 1863117-91-2 | Details |
| 1,3-Bis-aminooxy propane | C3H10N2O2 | 98627-69-1 | Details |
| DeBoc-Cabazitaxel | C40H49NO12 | 1638286-64-2 | Details |
| SMPH Crosslinker | C17H21N3O7 | 367927-39-7 | Details |
| Lycorine hydrochloride monohydrate | C16H20ClNO5 | 6150-58-9 | Details |
| NHPI-PEG2-C2-Pfp ester | C21H16F5NO7 | 2101206-47-5 | Details |
| PCSK9-IN-29 | C26H26FNO6S | 1233353-86-0 | Details |
| N,N-Diethanol amine-PEG4-Boc | C19H39NO8 | 2279944-66-8 | Details |
| N-Hydroxypipecolic acid potassium | C6H12KNO3 | 2253632-01-6 | Details |
| C.I. 15690 | C16H10N3NaO7S | 3179-84-8 | Details |
| JBJ-08-178-01 | C31H30N8O3 | 2401867-58-9 | Details |
| NADI-351 | C19H20FN5O4S2 | 2503017-11-4 | Details |
| (3S)Lenalidomide-5-Br | C13H11BrN2O3 | 2829898-76-0 | Details |
| AI 3-26464 | C20H16O6 | 493-95-8 | Details |
| NPC 567 | C60H87N19O13 | 109333-26-8 | Details |
| LK 11 | C15H26N2O3 | 74143-01-4 | Details |
| Dihydrocarminomycin | C26H29NO10 | 62182-86-9 | Details |
| SHP2-IN-31 | C21H26Cl2N4O2 | 2411321-35-0 | Details |
| BAY-593 | C26H31F3N2O3 | 2413020-56-9 | Details |
| N-Chlorosuccinimide | C4H4ClNO2 | 128-09-6 | Details |
| UNC8732 | C35H39N5O5 | 2929304-05-0 | Details |
| LysRs-IN-3 | C20H23N5O4S | 2841466-02-0 | Details |
| NSC-124854 | 1033942-30-1 | Details |
| YTHDC1-IN-1 | C13H11Cl2N5 | 2995344-53-9 | Details |
| Cholecystokinin Octapeptide, desulfated | C49H62N10O13S2 | 25679-24-7 | Details |
| Acid yellow 1 | C10H4N2Na2O8S | 846-70-8 | Details |
| Mal-NH-PEG4-CH2CH2COOPFP ester | C24H27F5N2O9 | 1347750-84-8 | Details |
| N-(Boc-PEG3)-N-bis(PEG3-acid) | C31H60N2O15 | 2055042-61-8 | Details |
| N-Biotin-N-bis(PEG4-acid) | C32H57N3O14S | 1964503-35-2 | Details |
| 9-Fluorenylmethyl carbamate | C15H13NO2 | 84418-43-9 | Details |
| sulfo-SPDB | C13H14N2O7S3 | 1193111-39-5 | Details |
| Exatecan Intermediate 2 | C13H15FN2O2 | 182182-31-6 | Details |
| BRPF1B/TRIM24-IN-1 | C24H25N3O7S | 1242907-48-7 | Details |
| endo-BCN-Fmoc-L-Lysine | C32H36N2O6 | 1493802-95-1 | Details |
| 4-Azido-2,3,5,6-tetrafluorobenzoic Acid | C7HF4N3O2 | 122590-77-6 | Details |
| Antioxidant 25 | C33H56N4OS2 | 991-84-4 | Details |
| h15-LOX-2 inhibitor 3 | C22H13N5O3 | 1164515-84-7 | Details |
| Product Total： Product Page： | ||||
| 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 | ||||